Monday, June 22

Browsing: Lobular

Survivors

54 Pleomorphic Invasive Lobular Carcinoma: Multimodality Imaging Findings in Cases From the University of Rochester Medical Center

By NewsCancerJune 22, 20260

BackgroundPleomorphic invasive lobular carcinoma (pILC) is a rare and aggressive morphologic variant of invasive lobular carcinoma (ILC), accounting for less…

Support

119 Progression-Free Survival (PFS) and Overall Survival (OS) Results From the Phase 3 MONALEESA-3 Trial of Postmenopausal Patients With Hormone Receptor–Positive (HR+)/Human Epidermal Growth Factor Receptor 2–Negative (HER2−) Advanced Breast Cancer (ABC) Treated With Ribociclib (RIB) + Fulvestrant (FUL): A Subgroup Analysis of Patients With Invasive Lobular Carcinoma (ILC)

By NewsCancerMay 11, 20260

BackgroundMONALEESA-3 reported statistically significant overall survival (OS) benefits with ribociclib plus fulvestrant, which were maintained with extended follow-up. Patients with…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

MOV10 suppresses circRNA biogenesis by disrupting reverse complementary matches structure to drive hepatocarcinogenesis

Jeremy Clarkson says he’s in remission from prostate cancer: ‘The doctors caught it early’ | Jeremy Clarkson

54 Pleomorphic Invasive Lobular Carcinoma: Multimodality Imaging Findings in Cases From the University of Rochester Medical Center

Browsing: Lobular

54 Pleomorphic Invasive Lobular Carcinoma: Multimodality Imaging Findings in Cases From the University of Rochester Medical Center

MOV10 suppresses circRNA biogenesis by disrupting reverse complementary matches structure to drive hepatocarcinogenesis

Jeremy Clarkson says he’s in remission from prostate cancer: ‘The doctors caught it early’ | Jeremy Clarkson

54 Pleomorphic Invasive Lobular Carcinoma: Multimodality Imaging Findings in Cases From the University of Rochester Medical Center

53 U.S. Patient Perspectives on Capivasertib Plus Fulvestrant: Dosing, Tolerability, and Blood Glucose Monitoring From Qualitative Interviews

MOV10 suppresses circRNA biogenesis by disrupting reverse complementary matches structure to drive hepatocarcinogenesis

Jeremy Clarkson says he’s in remission from prostate cancer: ‘The doctors caught it early’ | Jeremy Clarkson

54 Pleomorphic Invasive Lobular Carcinoma: Multimodality Imaging Findings in Cases From the University of Rochester Medical Center

53 U.S. Patient Perspectives on Capivasertib Plus Fulvestrant: Dosing, Tolerability, and Blood Glucose Monitoring From Qualitative Interviews

Latest Post

MOV10 suppresses circRNA biogenesis by disrupting reverse complementary matches structure to drive hepatocarcinogenesis

Jeremy Clarkson says he’s in remission from prostate cancer: ‘The doctors caught it early’ | Jeremy Clarkson

54 Pleomorphic Invasive Lobular Carcinoma: Multimodality Imaging Findings in Cases From the University of Rochester Medical Center

Subscribe to Updates

What's Hot

Browsing: Lobular